United States Patent and Trademark Office (USPTO) Cancels All Claims of Swift Medical's Patent

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

MolecuLight-USPTO

More Like This

MolecuLight Clinical Research Featured at the Upcoming SAWC Spring 2024 Conference

PR Newswire associated0

MolecuLight Awarded Federal Supply Contract for the US Department of Veterans Affairs

PR Newswire associated0

Pioneering Innovation from MolecuLight Earns Best Abstract at SAWC Spring 2024

PR Newswire associated0

MolecuLight's Pioneering Fluorescence Imaging Technology Showcased in Prestigious Burns Journal in Novel Study

PR Newswire associated0

MolecuLight's Profound Impact on Wound Healing Highlighted in Breaking Clinical Research

PR Newswire associated0

10 Clinical Posters Featuring MolecuLight Highlight its Progress Towards Becoming the Standard of Care

PR Newswire associated0

12 Posters and Presentations Featuring MolecuLight to be Presented at the SAWC Fall 2023 Conference

PR Newswire associated0

Latest Clinical Evidence Presented at APWCA's Wound Week™ 2023 Illustrates the Significant and New Clinical Utility of the MolecuLight Point-of-Care Imaging Platform